Your drug development solution provider

Dynakin offers a unique combination of expertise and capabilities covering the crucial pre-clinical, bioanalitical to strategic MBDD (Model Based Drug Development) based consulting and regulatory services.

The company collaborates with pharmaceutical and biotechnology companies, research sites, hospital services and universities in new therapeutic strategies development.

Why Dynakin

Because we are the sole organization providing one-stop pharmaceutics NCE development, formulation redesign and/or reindication from pre-clin to MAA with GLP Biolab to GCP CT to industry and regulatory-standard model based translational approaches.

Seeking consultation for drug development